| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |